HeartSciences Inc. (NASDAQ:HSCS) Short Interest Update

HeartSciences Inc. (NASDAQ:HSCS) was the recipient of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totaling 37,600 shares, a decrease of 65.6% from the September 15th total of 109,200 shares. Based on an average daily trading volume, of 125,200 shares, the days-to-cover ratio is currently 0.3 days. Currently, 1.4% of the company’s stock are short sold. Currently, 1.4% of the company’s stock are short sold. Based on an average daily trading volume, of 125,200 shares, the days-to-cover ratio is currently 0.3 days.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of HeartSciences in a research note on Tuesday, October 14th. Wall Street Zen upgraded HeartSciences from a “sell” rating to a “hold” rating in a report on Friday, October 3rd. Finally, Ascendiant Capital Markets decreased their target price on HeartSciences from $15.00 to $9.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $10.50.

HeartSciences Trading Down 2.1%

Shares of HSCS opened at $3.33 on Monday. The firm has a fifty day simple moving average of $3.51 and a two-hundred day simple moving average of $3.58. The firm has a market cap of $8.82 million, a PE ratio of -0.40 and a beta of 2.57. HeartSciences has a 1-year low of $2.52 and a 1-year high of $6.47.

HeartSciences (NASDAQ:HSCS) last issued its quarterly earnings data on Thursday, September 11th. The company reported ($1.58) EPS for the quarter, topping the consensus estimate of ($2.41) by $0.83. As a group, research analysts forecast that HeartSciences will post -10.01 EPS for the current fiscal year.

Institutional Investors Weigh In On HeartSciences

An institutional investor recently bought a new position in HeartSciences stock. Geode Capital Management LLC purchased a new stake in shares of HeartSciences Inc. (NASDAQ:HSCS) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 11,599 shares of the company’s stock, valued at approximately $43,000. Geode Capital Management LLC owned about 0.51% of HeartSciences as of its most recent SEC filing. 17.24% of the stock is currently owned by institutional investors.

HeartSciences Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.